Healthcare provider profile · identity verified

Thomas Scott Burkert, M.D.

Internal Medicine · POLAND, OH · NPI 1265493845

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	717	187
Levothyroxine Sodium	Levothyroxine Sodium	584	132
Amlodipine Besylate	Amlodipine Besylate	559	142
Lisinopril	Lisinopril	502	135
Rosuvastatin Calcium	Rosuvastatin Calcium	448	119
Metoprolol Succinate	Metoprolol Succinate	382	88
Metformin Hcl	Metformin Hcl	322	82
Eliquis	Apixaban	320	61
Losartan Potassium	Losartan Potassium	303	76
Simvastatin	Simvastatin	211	56
Lorazepam	Lorazepam	202	40
Metoprolol Tartrate	Metoprolol Tartrate	197	53
Pantoprazole Sodium	Pantoprazole Sodium	197	57
Alendronate Sodium	Alendronate Sodium	183	56
Synthroid	Levothyroxine Sodium	176	50
Potassium Chloride	Potassium Chloride	173	48
Donepezil Hcl	Donepezil Hcl	160	39
Tamsulosin Hcl	Tamsulosin Hcl	159	47
Escitalopram Oxalate	Escitalopram Oxalate	155	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	154	43
Glimepiride	Glimepiride	152	36
Omeprazole	Omeprazole	148	39
Hydrochlorothiazide	Hydrochlorothiazide	145	43
Ozempic	Semaglutide	134	17
Carvedilol	Carvedilol	133	30
Gabapentin	Gabapentin	129	37
Furosemide	Furosemide	124	40
Allopurinol	Allopurinol	109	30
Trazodone Hcl	Trazodone Hcl	108	19
Prednisone	Prednisone	104	71
Pravastatin Sodium	Pravastatin Sodium	97	24
Clonazepam	Clonazepam	93	12
Alprazolam	Alprazolam	91	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	27
Doxycycline Hyclate	Doxycycline Hyclate	86	75
Jardiance	Empagliflozin	86	21
Mirtazapine	Mirtazapine	84	21
Januvia	Sitagliptin Phosphate	81	19
Tramadol Hcl	Tramadol Hcl	81	18
Citalopram Hbr	Citalopram Hydrobromide	78	22
Clopidogrel	Clopidogrel Bisulfate	73	21
Duloxetine Hcl	Duloxetine Hcl	73	21
Meclizine Hcl	Meclizine Hcl	73	29
Bupropion Xl	Bupropion Hcl	71	17
Atenolol	Atenolol	64	17
Oxybutynin Chloride Er	Oxybutynin Chloride	63	16
Ezetimibe	Ezetimibe	62	18
Valsartan	Valsartan	62	15
Paroxetine Hcl	Paroxetine Hcl	57	15
Meloxicam	Meloxicam	56	16
Cefdinir	Cefdinir	54	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	50	suppressed
Famotidine	Famotidine	49	14
Triamcinolone Acetonide	Triamcinolone Acetonide	49	32
Xarelto	Rivaroxaban	49	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	13
Sertraline Hcl	Sertraline Hcl	48	14
Temazepam	Temazepam	44	suppressed
Montelukast Sodium	Montelukast Sodium	43	12
Warfarin Sodium	Warfarin Sodium	43	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	11
Trulicity	Dulaglutide	41	suppressed
Calcitriol	Calcitriol	39	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Finasteride	Finasteride	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	19
Bumetanide	Bumetanide	28	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Spironolactone	Spironolactone	26	suppressed
Azithromycin	Azithromycin	25	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	15
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	21
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	21	suppressed
Cephalexin	Cephalexin	20	15
Lansoprazole	Lansoprazole	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Mupirocin	Mupirocin	19	17
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	12
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Digoxin	Digoxin	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Levoxyl	Levothyroxine Sodium	17	suppressed
Torsemide	Torsemide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Levofloxacin	Levofloxacin	13	13
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Baclofen	Baclofen	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Methimazole	Methimazole	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error